Volume | 31,789 |
|
|||||
News | - | ||||||
Day High | 0.54 | Low High |
|||||
Day Low | 0.4801 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Catheter Precision Inc | VTAK | AMEX | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
0.54 | 0.4801 | 0.54 | 0.52 | 0.54 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
134 | 31,789 | US$ 0.5191815 | US$ 16,504 | - | 0.34 - 0.748 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
19:00:00 | 100 | US$ 0.52 | USD |
Catheter Precision Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
61.98M | 7.03M | - | 442k | -70.57M | -10.04 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Catheter Precision News
Date | Time | Source | News Article |
---|---|---|---|
6/03/2024 | 15:21 | Edgar (US Regulatory) | Form 8-K - Current report |
5/21/2024 | 15:16 | Edgar (US Regulatory) | Form 8-K - Current report |
5/16/2024 | 16:12 | Edgar (US Regulatory) | Form ARS - Annual Report to Security Holders |
5/16/2024 | 16:09 | Edgar (US Regulatory) | Form DEFA14A - Additional definitive proxy soliciting.. |
5/07/2024 | 15:15 | Edgar (US Regulatory) | Form 8-K - Current report |
5/06/2024 | 16:03 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
1/25/2024 | 15:15 | Edgar (US Regulatory) | Form 8-K - Current report |
1/11/2024 | 15:15 | Edgar (US Regulatory) | Form 8-K - Current report |
1/10/2024 | 15:31 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
1/08/2024 | 15:45 | Edgar (US Regulatory) | Form 3 - Initial statement of beneficial ownership of.. |
1/04/2024 | 15:20 | Edgar (US Regulatory) | Form 8-K - Current report |
12/29/2023 | 07:58 | Edgar (US Regulatory) | Form 8-K - Current report |
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical VTAK Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.5219 | 0.5457 | 0.48 | 0.5190464 | 26,125 | -0.0019 | -0.36% |
1 Month | 0.60 | 0.65 | 0.48 | 0.5634381 | 40,811 | -0.08 | -13.33% |
3 Months | 0.5795 | 0.65 | 0.40 | 0.5407182 | 36,213 | -0.0595 | -10.27% |
6 Months | 0.482 | 0.748 | 0.3704 | 0.5029382 | 45,224 | 0.038 | 7.88% |
1 Year | 0.60 | 0.748 | 0.34 | 0.4746927 | 47,258 | -0.08 | -13.33% |
3 Years | 0.60 | 0.748 | 0.34 | 0.4746927 | 47,258 | -0.08 | -13.33% |
5 Years | 0.60 | 0.748 | 0.34 | 0.4746927 | 47,258 | -0.08 | -13.33% |
Catheter Precision Description
Ra Medical Systems Inc is a commercial-stage medical device company leveraging its laser-based platform for use in the treatment of vascular diseases. Its products restore blood-flow in arteries and clearing chronic skin conditions. The firm's products include DABRA and Pharos. DABRA System is used as a tool in the treatment of peripheral artery disease, or PAD, a form of peripheral vascular disease, which commonly occurs in the legs. Pharos is designed for use in the treatment of inflammatory skin conditions and as a tool in the treatment of psoriasis, vitiligo, atopic dermatitis, and leukoderma. |